Roche calls offer for Illumina "starting point"
Read this article
hotklixed More than a Year Ago! (Reuters) - Swiss drugmaker Roche Holding AG, in a letter to Illumina Inc shareholders, called its sweetened $51-a-share offer for the maker of genetic analysis equipment "a more than reasonable starting point for negotiations."
By shradha | More than a Year Ago
Source: feeds.reuters.com
Advertisement




